Non-alcoholic fatty liver disease: understanding the role of aging, fatty acid transporter and epigenetics
12-1-2015, Fareeba Sheedfar
New perspectives in immunomodulating mechanisms of Intravenous Immunoglobulins: towards safer immunosuppression after liver transplantation
19-11-2014, Angela S.W. Tjon
Chronic Hepatitis B infection: new insights in therapy and predictors of response
24-9-2014, Pauline Arends
Antiviral therapy for chronic HCV infection: virological response and long-term outcome
24-9-2014, A.J.P. van der Meer
Mice with humanized liver endothelium
24-9-2014, E.E. Filali
De gepolariseerde architectuur van hepatocyten: regulatie door intrinsieke en extrinsieke factoren
3-9-2014, C.L. Slim
Pharmacotherapeutic options in sarcoidosis: how can we improve them?
26-6-2014, Anne (J.P.) Cremers
Antioxidant adaptations in liver fibrogenesis
16-4-2014, Marjolein H. Tiebosch
Diagnosis and treatment of unconjugated hyperbilirubinemia: experimental and clinical aspects
12-2-2014, A.B. Schreuder
ABC transporters as therapeutic targets for liver fibrosis
6-1-2014, A.U. Rehman